- Transcriptic and 3scan merged to form Strateos, announcing ~$20 M in new funding to scale robotic automation of pharmaceutical laboratories.  
- A new pre-print describes “Ultrafast immunostaining of organ-scale tissues,” a method that enables scalable, whole-organ proteomic phenotyping (bioRxiv 10.1101/660373v1).  
- Researchers placed an optically pumped magnetometer (OPM) inside the mouth to non-invasively record hippocampal theta oscillations, demonstrating a novel approach to high-resolution brain-state monitoring.  
- A CRISPR-based “Cas-transposon” system for programmable, precise DNA transpositions was released on bioRxiv (10.1101/654996v1), potentially expanding genome-engineering toolkits.  
- Gap-junction modulation in C. elegans was shown to regulate aging and lifespan, offering a new mechanistic link between neural connectivity and longevity (bioRxiv 10.1101/657817v1).  
- MIT-linked startup SelectaBio is using nanoparticle-induced immune tolerance to rescue FDA-approved drugs that are shelved or labeled for immune-related adverse events.  
- The $2 million gene-therapy Zolgensma sparked debate on drug pricing; a patient-authored STAT op-ed argued that society should not place monetary limits on life-saving treatments.  
- Jeff Clune et al. released “AI-GAs: AI-generating algorithms,” an arXiv paper (1905.10985) proposing that meta-learning systems that generate AI architectures could outperform hand-designed pipelines.  
- A single-cell atlas of mouse-brain macrophages was published by Nature Biotechnology, providing a comprehensive reference for neuro-immune interactions.  
- Naked mole-rats continue to defy Gompertzian mortality laws, showing no age-related increase in death rate over 30 years, reinforcing their status as a unique model organism for longevity research (eLife 2019).